Inferior control arms in oncology trials in LMICs: contextualised or compromised?
- PMID: 40909186
- PMCID: PMC12406892
- DOI: 10.1136/bmjonc-2025-000931
Inferior control arms in oncology trials in LMICs: contextualised or compromised?
Keywords: Clinical Trial; Medical oncology.
Conflict of interest statement
LAT has received honoraria from AstraZeneca, unrelated to the manuscript. BG has received consulting fees from Vivio Health, unrelated to the manuscript.
Comment on
-
Analysis of control arms in oncology randomised trials in Brazil: a cross-sectional study.BMJ Oncol. 2025 Aug 4;4(1):e000808. doi: 10.1136/bmjonc-2025-000808. eCollection 2025. BMJ Oncol. 2025. PMID: 40765840 Free PMC article.
References
-
- World Medical Association . World Med Assoc; 2024. [25-Jul-2025]. WMA declaration of helsinki − ethical principles for medical research involving human subjects.https://www.wma.net/policies-post/wma-declaration-of-helsinki/ Available. Accessed. - PubMed
Publication types
LinkOut - more resources
Full Text Sources